A recent study revealed that people who stop consuming popular weight-loss drugs such as Ozempic and Wegovy are expected to rapidly regain much of their weight.Researchers assessed 37 earlier studies involving about 9,

Glucagon-like peptide-1 receptor agonists (GLP-1s or GLP-1RAs) – also known as weight-loss jabs – are medicines that help people feel fuller by mimicking a natural hormone released after eating, according to the GOV.UK website.

GLP‑1 medications such as Ozempic and Wegovy work by mimicking a hormone that signals fullness to the brain and gut. But once the injections stop, experts warn the body may begin producing less of that natural hormone and may also become less sensitive to it — increasing the likelihood of overeating.

Weight-loss experts reveal their major predictions for 2026, from advanced GLP-1 treatments to AI-driven personalized therapy and minimally invasive procedures.

Like diabetes or BP medicines, these drugs work only as long as you take them, says endocrinologist Dr Ambrish Mithal. Dose reduction and long-term weight maintenance are key

Will 2026 mark the end of crash dieting? Experts reveal the truth behind weight loss myths, metabolism damage and why slow change finally wins.